CORRECTION – Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test IRVINE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) — MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that addresses unmet clinical needs, announced today corrections to the second paragraph of its press release under the same headline […]
Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test IRVINE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) — MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests addressing unmet clinical needs, is excited to announce that its SmartVascular Dx™ (SVDx) test, formerly known as the PULS™ Cardiac Test, is […]
SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS IRVINE, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) — MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests addressing unmet clinical needs, is excited to announce that its SmartVascular Dx™ (SVDx) test, formerly known as the PULS™ Cardiac […]
Advancing Preventive Vascular Inflammation in the South with SmartVascular Dx™ Test IRVINE, Calif., July 17, 2025/GLOBE NEWSWIRE/–MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, is proud to announce the expansion of the SmartVascular Dx™ test (formally known as the PULS™ Cardiac Test) into southern states. […]
SmartVascular Dx™ Test: Enhancing Vascular Care in the Midwest IRVINE, Calif., June 25, 2025/GLOBE NEWSWIRE/–MorningStar Laboratories, LLC., (“MSL” or “the Company”), is a leading developer of precision diagnostic tests that address unmet clinical needs, is proud to announce its expansion in the Midwest with the introduction of the SmartVascular Dx™ test (formally known as the PULS™ […]
Expanding Access in California: SmartVascular Dx™ Test Now Available Through Major Health Plan IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) — MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, is excited to announce that theSmartVascular Dx™ test (formally known as the PULS™ Cardiac Test) is […]
SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) — MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly announces its SmartVascular Dx™ (SVDx) test (formally known as the PULS Cardiac test), designed to transform the early detection and management […]
